Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors
about
Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@ast
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@en
type
label
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@ast
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@en
prefLabel
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@ast
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@en
P2093
P2860
P921
P1433
P1476
Early anti-TNF/immunomodulator ...... e with poor prognostic factors
@en
P2093
Dong-Hoon Yang
Eun Hye Oh
Eun Mi Song
Gwang-Un Kim
Hyungil Seo
Jeong-Sik Byeon
Kiju Chang
Kyung-Jo Kim
Kyunghwan Oh
P2860
P304
P356
10.1371/JOURNAL.PONE.0177479
P407
P50
P577
2017-05-23T00:00:00Z